pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 23·1 min read
save

Congress rushes health-care bills on price transparency and prior authorization before August recess

Jul 23, 2026·read at STAT ↗RegulatoryNeutral

Congress is trying to pass a bundle of health-care legislation in the final week before the House and Senate adjourn for the August recess.

Lawmakers are focusing on measures that would increase price transparency for medical services and drugs, aiming to give patients clearer cost information.

Another priority is reforming prior-authorization procedures, with proposals intended to streamline the process and reduce delays in patient care.

The flurry of activity comes as both chambers will be in session separately for part of the period, adding pressure to move bills quickly before the September recess.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: What’s in the last-minute flurry of health care bills?”

read at STAT ↗
431 words · retrieved Jul 23
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
drugs
Rare Disease
topics
GLP-1 receptorRare Disease

related stories

  • 3d agoSTAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and moreSTAT
  • 6d agoLilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist MounjaroBioSpace
  • Aug 24STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and moreSTAT
  • Aug 20Reduce protein to increase longevity? Nutrition experts say that’s a bad ideaSTAT
  • Aug 18Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemiaBioSpace